Transaction DateRecipientSharesTypePriceValue
Cell Source
Cell Source logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 5/10.


Cell Source, Inc. was founded on June 6, 2012 and is headquartered in New York, NY. The firm's lead product, Veto-Cell immune system management technology, is an immune tolerance biotechnology.


Ticker: CLCS
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1569340
Employees:
Exchange: US OTC
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals